Rosiglitazone Treatment in Zucker Diabetic Fatty Rats Is Associated With Ameliorated Cardiac Insulin Resistance and Protection From Ischemia/Reperfusion-Induced Myocardial Injury

Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor

Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594

Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)

Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,860

The renaissance of GSK3

Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,401

Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway

Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,046

Myocardial Cell Death in Human Diabetes

Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B., & Anversa, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1123 · Cited by 796

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ

Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16885 · Cited by 726

Impact of Diabetes on Mortality After the First Myocardial Infarction

Miettinen, H., Lehto, S., Salomaa, V., Mähönen, M., Niemelä, M., Haffner, S. M., Pyörälä, K., Tuomilehto, J., & The FINMONICA Myocardial Infarction Register Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.1.69 · Cited by 665

A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2

George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 562

Adaptation and Maladaptation of the Heart in Diabetes: Part I

Taegtmeyer, H., McNulty, P. H., & Young, M. E. (2002) · Circulation · doi:10.1161/01.cir.0000012466.50373.e8 · Cited by 520

The Cardioprotective Actions of Leptin Are Lost in the Zucker Obese (fa/fa) Rat

Dixon, R. A., Davidson, S. M., Wynne, A. M., Yellon, D. M., & Smith, C. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31819d6152 · Cited by 23

Peroxisome Proliferator-Activated Receptor Gamma Agonists in Kidney Disease – Future Promise, Present Fears

Mao, Z., & Ong, A. C. M. (2009) · Nephron Clinical Practice · doi:10.1159/000224789 · Cited by 24

The Insulin Sensitizer Pioglitazone Improves the Deterioration of Ischemic Preconditioning in Type 2 Diabetes Mellitus Rats

Sasaki, H., Ogawa, K., Shimizu, M., Mori, C., Takatsuka, H., Okazaki, F., Kawai, M., Taniguchi, I., & Mochizuki, S. (2007) · International Heart Journal · doi:10.1536/ihj.48.623 · Cited by 24

Thiazolidinediones—improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes

Dandona, P., Ghanim, H., Chaudhuri, A., & Mohanty, P. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.10.009 · Cited by 23

Rosiglitazone Protects against Ischemia/Reperfusion-Induced Leukocyte Adhesion in the Zucker Diabetic Fatty Rat

Johns, D. G., Ao, Z., Eybye, M., Olzinski, A., Costell, M., Gruver, S., Smith, S. A., Douglas, S. A., & Macphee, C. H. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090993 · Cited by 22

Impairment of the Vascular KATP Channel Imposes Fatal Susceptibility to Experimental Diabetes Due to Multi‐Organ Injuries

Li, S.-S., Cui, N., Yang, Y., Trower, T. C., Wei, Y.-Y., Wu, Y., Zhang, S., Jin, X., & Jiang, C. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25003 · Cited by 21

The Impact of Current and Novel anti-diabetic Therapies On Cardiovascular Risk

Ussher, J. R., Sutendra, G., & Jaswal, J. S. (2012) · Future Cardiology · doi:10.2217/fca.12.68 · Cited by 21

PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure

Mistry, N. F., & Cresci, S. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9114-x · Cited by 22

Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism

van den Brom, C. E., Bulte, C. S. E., Loer, S. A., Bouwman, R. A., & Boer, C. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-42 · Cited by 24

PPARα agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes

Nan, W. Q., Shan, T. Q., Qian, X., Wu, P., Bing, G. A., & Ying, L. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347084 · Cited by 22

Prolonged exposure to GH impairs insulin signaling in the heart

Miquet, J. G., Giani, J. F., Martinez, C. S., Muñoz, M. C., González, L., Sotelo, A. I., Boparai, R. K., Masternak, M. M., Bartke, A., Dominici, F. P., et al. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0066 · Cited by 20

Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus

Pop‐Busui, R., Oral, E. A., Raffel, D. M., Byun, J., Bajirovic, V., Vivekanandan‐Giri, A., Kellogg, A. P., Pennathur, S., & Stevens, M. J. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.020 · Cited by 20

Thiazolidinediones

Reynolds, K., & Goldberg, R. B. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605010-00004 · Cited by 20

Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?

Hemmeryckx, B., Hoylaerts, M., Gallacher, D. J., Lu, H. R., Himmelreich, U., D’hooge, J., Swinnen, M., & Lijnen, H. R. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.062 · Cited by 19

The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial

McGavock, J., Szczepaniak, L. S., Ayers, C. R., Abdullah, S. M., See, R., Gore, M. O., Drazner, M. H., de Lemos, J. A., & McGuire, D. K. (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111428628 · Cited by 18

Differential nutritional, endocrine, and cardiovascular effects in obesity-prone and obesity-resistant rats fed standard and hypercaloric diets.

de Oliveira-Junior, S. A., Dal‐Pai‐Silva, M., Martinez, P. F., de Campos, D. H. S., Lima‐Leopoldo, A. P., Leopoldo, A. S., do Nascimento, A. F., Okoshi, M. P., Okoshi, K., Padovani, C. R., et al. (2010) · PubMed · Cited by 18

Effects of Chronic Rosiglitazone Treatment on Renal Handling of Salt and Water in Rats With Volume-Overload Congestive Heart Failure

Goltsman, I., Wang, X., LaVallie, E. R., DiBlasio-Smith, E. A., Ovcharenko, E., Hoffman, A., Abassi, Z. A., Feuerstein, G., & Winaver, J. M. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960179 · Cited by 17

Effects of Rosiglitazone (a Peroxysome Proliferator-Activated Receptor .GAMMA. Agonist) on the Blood Pressure and Aortic Structure in Metabolically Programmed (Perinatal Low Protein) Rats

Torres, T. D. S., SILVA, G. D., Águila, M. B., de Carvalho, J. J., & Mandarim‐de‐Lacerda, C. A. (2008) · Hypertension Research · doi:10.1291/hypres.31.965 · Cited by 16

Evaluation of the relationship between hyperinsulinaemia and myocardial ischaemia/reperfusion injury in a rat model of depression

Solskov, L., Løfgren, B., Pold, R., Kristiansen, S. B., Nielsen, T. T., Overstreet, D. H., Schmitz, O., Bøtker, H. E., Lund, S. A., & Wegener, G. (2009) · Clinical Science · doi:10.1042/cs20090108 · Cited by 16

Intervention of rosiglitazone on myocardium Glut-4 mRNA expression during ischemia–reperfusion injury in cardio-pulmonary bypass in dogs

Liu, B., Liang, G., Xu, G., Liu, D., Cai, Q., & Gao, Z. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1501-x · Cited by 15

Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin indb/dbdiabetic mice

Alawi, L. F., Emberesh, S. E., Owuor, B. A., Chodavarapu, H., Fadnavis, R., El‐Amouri, S. S., & Elased, K. M. (2020) · Physiological Reports · doi:10.14814/phy2.14364 · Cited by 14

How to revascularize patients with diabetes mellitus—

Elsässer, A., Möllmann, H., NEF, H. M., & Hamm, C. W. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0365-z · Cited by 15

Effects of rosiglitazone ( PPAR γ agonist) on the myocardium in non‐hypertensive diabetic rats 罗格列酮（PPAR γ 激动剂）对非高血压糖尿病大鼠的心肌的影响

Abou‐Daya, K. I., Daya, H. A., Nassereddine, M., Nahhas, G. J., & Nuwayri‐Salti, N. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12140 · Cited by 14

Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats

Silva-Júnior, G. O., Torres, T. D. S., Mendonça, L. D. S., & Mandarim‐de‐Lacerda, C. A. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.09.001 · Cited by 14

Cardiovascular pharmacotherapy: Innovation stuck in translation

Rongen, G. A. P. J. M., & Wever, K. E. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.035 · Cited by 14

Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring

Torres, T. D. S., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.03.007 · Cited by 14

The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics

Cresci, S. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2577 · Cited by 13

Early diabetes treatment does not prevent sympathetic dysinnervation in the streptozotocin diabetic rat heart

Thackeray, J. T., deKemp, R. A., Beanlands, R. S., & DaSilva, J. N. (2014) · Journal of Nuclear Cardiology · doi:10.1007/s12350-014-9900-x · Cited by 12

PDHA1 Alleviates Myocardial Ischemia-Reperfusion Injury by Improving Myocardial Insulin Resistance During Cardiopulmonary Bypass Surgery in Rats

Chen, K., Liu, Z., Yi, J., Hui, Y.-P., Song, Y., Lu, J., Chen, H., Yang, S., Hu, X., Zhang, D., et al. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07501-9 · Cited by 11

Whole Transcriptome Analysis of Hypertension Induced Cardiac Injury Using Deep Sequencing

Li, T., Li, X., Jia, L., Zhang, J., Zhang, W.-M., Li, Y., Qi, Y., & Du, J. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438659 · Cited by 11

Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.

Rehni, A. K., & Dave, K. R. (2018) · PubMed · Cited by 10

Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin

Semple, D. J., Bhandari, S., & Seymour, A. L. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00048.2012 · Cited by 10

Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo

Weber, B. Y., Brenner, G. B., Kiss, B., Gergely, T. G., Sayour, N. V., Tian, H., Makkos, A., Görbe, A., Ferdinandy, P., & Giricz, Z. (2022) · Pharmaceuticals · doi:10.3390/ph15091055 · Cited by 8

Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia

Zhang, W.-L., Yan, W., Sun, B., & Zou, Z.-P. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-168 · Cited by 8

High sugar diet–induced fatty acid oxidation potentiates cytokine-dependent cardiac ECM remodeling

Gera, J., Kumar, D., Chauhan, G., Choudhary, A., Rani, L., Mandal, L., & Mandal, S. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202306087 · Cited by 8

The Failing Heart: Is It an Inefficient Engine or an Engine Out of Fuel?

Masoud, W. G. T., Clanachan, A. S., & Lopaschuk, G. D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5930-9_4 · Cited by 7

Cardiac substrate metabolism in type 2 diabetes

Chan, J. S. F., Shafaati, T., & Ussher, J. R. (2025) · Biochemical Journal · doi:10.1042/bcj20240189 · Cited by 6

Vascular Biology Protocols

(2007) · Methods in molecular medicine · doi:10.1007/978-1-59745-571-8 · Cited by 6

Optimizing cardiac energy substrate metabolism: a novel therapeutic intervention for ischemic heart disease

Jaswal, J. S., Cadete, V. J. J., & Lopaschuk, G. D. (2008) · Heart and Metabolism · Cited by 5

Thiazolidinediones and vascular damage

Goldberg, R. B. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328054c655 · Cited by 5

The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair

Zivarpour, P., Reiner, Ž., Hallajzadeh, J., Mirsafaei, L., & Asemi, Z. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09980-6 · Cited by 3

Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?

Szebeni, A., Szentandrássy, N., Pacher, P., Simkó, J., Nánási, P. P., & Kecskeméti, V. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796642364 · Cited by 3

Rat Models of Cardiac Insulin Resistance

Ghosh, S., Rodrigues, B. B., & Ren, J. T. (2007) · Methods in molecular medicine · doi:10.1007/978-1-59745-571-8_7 · Cited by 3

Tissue Distribution and Versatile Functions of PPARs

Youssef, J., & Badr, M. Z. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-420-3_5 · Cited by 2

Obesity and Cardiometabolic Defects in Heart Failure Pathology

Halade, G. V., & Kain, V. (2017) · Comprehensive physiology · doi:10.1002/j.2040-4603.2017.tb00788.x · Cited by 2

Molecular Changes in Fatty Acid Oxidation in the Failing Heart

Jaswal, J. S., Keung, W., Wang, W., Ussher, J. R., & Lopaschuk, G. D. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7130-2_12 · Cited by 2

Renoprotective Effects of Rosiglitazone in Stroke-Prone Spontaneously Hypertensive Rats

Choi, B. S., Yang, H. J., Ahn, K. O., Lim, S. W., Kim, S. H., Kim, J. Y., Li, C., Kim, Y., Kim, J., Bang, B. K., et al. (2007) · Kidney & Blood Pressure Research · doi:10.1159/000104090 · Cited by 2

Acute calcitriol treatment alleviates cerebral ischemia reperfusion injury via activation of MasR/PI3K/Akt/CREB axis and suppression of AT-1R/NF-κB p65 signaling cascade

Eltwab, D. A., Rabie, M. A., Mohamed, R. A., & Elyamany, M. F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178240 · Cited by 1

Cardiac Metabolism and Energetic Control

Rohrbach, S., & Niemann, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-31251-4_4 · Cited by 1

Un contrato de empeño y un poder en un documento hebreo de Tudela

Riaño, J. L. L. (1984) · Sefarad · Cited by 1

Diyabetik ve diyabetik olmayan sıçanlarda flep yaşayabilirliğine “Rosiglitazon”un etkisinin araştırılması

ERGÜN, K. B. (2012) · Ankara Üniversitesi Tıp Fakültesi Mecmuası · doi:10.1501/tipfak_0000000821 · Cited by 1

Effect on the Akt2 in skeletal muscle of rats with insulin resistance treated by acupuncture

Zhang, L., Li, M., Wei, Y., Xu, N., & Sun, J. (2010) · Journal of Acupuncture and Tuina Science · doi:10.1007/s11726-010-0426-8 · Cited by 1

Gene Expression of GSK3 in Type II Diabetics Compared to Non-Diabetics (ex vivo)

Khorami, S. A. H., Mutalib, M. S. A., Shiraz, M. F., Abdullah, J. A., Rejali, Z., Ali, R. M., & Khaza’ai, H. (2020) · The Open Diabetes Journal · doi:10.2174/1876524602010010030 · Cited by 2

CARDIAC DYSFUNCTION IN THE ZDF RAT: POSSIBLE MECHANISMS AND BENEFITS OF EXERCISE

VanHoose, L. (2011) · KU ScholarWorks (The University of Kansas) · Cited by 1

A critical analysis of mitochondrial functioning and associated proteins in obesity-related cardiomyopathy

George, S. (2013) · SUNScholar (Stellenbosch University) · Cited by 1

A PATHOLOGIC ROLE FOR ANGIOTENSIN II AND ENDOTHELIN-1 IN CARDIAC REMODELLING AND ISCHAEMIA AND REPERFUSION INJURY IN A RAT MODEL OF THE METABOLIC SYNDROME.

Smith, W. T. (2006) · SUNScholar (Stellenbosch University) · Cited by 1

Tools to enable animal to human translation

Ferreira, G. S. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/157 · Cited by 1

Putative role of palmitate and Akt signaling in attenuating skeletal muscle growth in the obese zucker rat

Peterson, J. M. (2008) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.2713

Molecular Mechanisms of Post-Ischemic Angiogenesis in the Brain

Beck, H. (2010) · Springer eBooks · doi:10.1007/978-90-481-9495-7_6

Cardioprotective Effect of Ischemic Preconditioning on Ischemia/Reperfusion Injury in Spontaneously Type 2 Diabetic Rat Hearts (Original)

Mori, C., Ogawa, K., Takatsuka, H., Anzawa, R., Taniguchi, I., & Shimizu, M. (2006) · Institutional Repositories DataBase (IRDB)

The Role of Complement in Ischemic Heart Disease in Type 2 Diabetes Mellitus

Bonte, L. R. L. (2008) · UA Campus Repository (The University of Arizona)

The role of adiponectin in ischemia -reperfusion injury in the type 2 diabetic heart

Choi, J. (2008) · UA Campus Repository (The University of Arizona)

RAGE and Modulation of Ischemic Injury in the Diabetic

Sell, D. R., Strauch, C., Monnier, V. M., Fang, S., Schmidt, A. M., & Ramasamy, R. (2008)

Obesity and Cardiac Dysfunction

Sweeney, G., Litwin, S. E., & Abel, E. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_14

Cardiac Energy Metabolism: A Potential Novel Therapeutic Target in the Treatment of Ischemic Heart Diseases

Alrob, O. A. (2018) · Jordan Journal of Pharmaceutical Sciences

Metabolic efficiency in remodeled failing hearts

Masoud, W. G. T. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r39s1ks1s

EVALUATION OF THE ANTI-ISCHEMIC EFFECT OF THE PPARy AGONIST, (ROSIGLITAZONE) IN PERMANENT FOCAL CEREBRAL ISCHEMIA IN DIABETIC RATS.

Shalaby, A. A., & Boshra, V. (2008) · Mansoura Medical Journal · doi:10.21608/mjmu.2008.128912

Preclinical and clinical evaluation of a new method to assess cardiac insulin resistance using nuclear imaging

Perret, P., Slimani, L., Barone‐Rochette, G., Vollaire, J., Briat, A., Ahmadi, M., Henri, M., Desruet, M.-D., Clerc, R., Broisat, A., et al. (2021) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02520-7

Current literature in diabetes

(2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.604

The effect of CPT-1 inhibition on myocardial function and resistance to ischemia/reperfusion injury in a rodent model of the metabolic syndrome

Maarman, G. J. (2010) · SUNScholar (Stellenbosch University)

Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart

Sidell, R. J., Cole, M. A., Draper, N. J., Desrois, M., Buckingham, R. E., & Clarke, K. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1110 · Cited by 165

Rosiglitazone‐induced myocardial protection against ischaemia–reperfusion injury is mediated via a phosphatidylinositol 3‐kinase/Akt‐dependent pathway

Zhang, X., Xiong, Z., Tang, A., Ma, H., Ma, Y., Wu, J., & Dong, Y. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05232.x · Cited by 26

Abstract 9827: Acute Rosiglitazone Treatment is Cardioprotective Against Ischemia/Reperfusion Injury by Modulating AMPK, Akt, and JNK Signaling in Non-Diabetic Mice

Morrison, A., Yan, X., & Li, J. (2011) · Circulation · doi:10.1161/circ.124.suppl_21.a9827 · Cited by 2

Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat

Clarke, K. (2016)

Rosiglitazone Improves Cardiac Performance After Myocardial Ischemia/Reperfusion Injury and Glucose Metabolic in Obese Rats

Zhou, B. (2009) · Chinese Journal of Hypertension